ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 130 filers reported holding ACLARIS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.11 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,603 | +81.1% | 234,150 | +174.2% | 0.00% | 0.0% |
| Q2 2023 | $885 | -42.0% | 85,389 | -54.7% | 0.00% | – |
| Q1 2023 | $1,526 | +126.4% | 188,690 | +340.8% | 0.00% | – |
| Q4 2022 | $674 | -99.7% | 42,810 | +156.2% | 0.00% | – |
| Q3 2022 | $263,000 | -14.3% | 16,707 | -24.0% | 0.00% | – |
| Q2 2022 | $307,000 | -70.5% | 21,969 | -63.5% | 0.00% | -100.0% |
| Q1 2022 | $1,039,000 | -64.4% | 60,256 | -70.0% | 0.00% | 0.0% |
| Q4 2021 | $2,922,000 | +223.6% | 201,036 | +300.7% | 0.00% | – |
| Q3 2021 | $903,000 | +340.5% | 50,169 | +326.4% | 0.00% | – |
| Q2 2021 | $205,000 | – | 11,767 | +65272.2% | 0.00% | – |
| Q1 2021 | $0 | – | 18 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 18 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 18 | -99.8% | 0.00% | – |
| Q2 2020 | $13,000 | +18.2% | 8,294 | -21.1% | 0.00% | – |
| Q1 2020 | $11,000 | -93.1% | 10,516 | -87.5% | 0.00% | – |
| Q4 2019 | $159,000 | +783.3% | 83,853 | +389.9% | 0.00% | – |
| Q3 2019 | $18,000 | -64.0% | 17,118 | -25.6% | 0.00% | – |
| Q2 2019 | $50,000 | -20.6% | 23,015 | +119.5% | 0.00% | – |
| Q1 2019 | $63,000 | -64.6% | 10,483 | -14.4% | 0.00% | – |
| Q3 2018 | $178,000 | +356.4% | 12,243 | +523.4% | 0.00% | – |
| Q2 2018 | $39,000 | -64.9% | 1,964 | -69.2% | 0.00% | – |
| Q1 2018 | $111,000 | -0.9% | 6,378 | +40.7% | 0.00% | – |
| Q4 2017 | $112,000 | -41.7% | 4,532 | -39.2% | 0.00% | – |
| Q3 2017 | $192,000 | +1180.0% | 7,457 | +1248.5% | 0.00% | – |
| Q2 2017 | $15,000 | -91.0% | 553 | -90.1% | 0.00% | – |
| Q1 2017 | $167,000 | +15.2% | 5,608 | +4.8% | 0.00% | – |
| Q4 2016 | $145,000 | +3525.0% | 5,350 | +3396.7% | 0.00% | – |
| Q3 2016 | $4,000 | -84.6% | 153 | -84.7% | 0.00% | – |
| Q4 2015 | $26,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |